A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Carrie Cwiak, Emory University
ClinicalTrials.gov Identifier:
NCT00253019
First received: November 14, 2005
Last updated: August 10, 2013
Last verified: August 2013

November 14, 2005
August 10, 2013
October 2004
November 2005   (final data collection date for primary outcome measure)
Continuation Rates [ Time Frame: 3 months ] [ Designated as safety issue: No ]
We followed subjects to evaluate the continuation rates for subjects receiving oral contraceptive pills, Depo Provera and Ortho Evra.
Not Provided
Complete list of historical versions of study NCT00253019 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods
A Comparison of Continuation Rates for Three Hormonal Contraceptive Methods (Oral Contraceptive Pills, Depo Provera and Ortho Evra) Among Women Seeking First Trimester Abortion.

This study will assess the continuation rates among women using oral contraceptive pills, Depo-Provera and Ortho Evra following a first trimester abortion.

Unintended pregnancy rates among women in the United States continue to surpass that of the rest of the developed world at great cost to society. Contraceptive failure has been attributed to poor compliance with contraceptive methods and results in unintended pregnancies. This study will evaluate the 3-month continuation rates among women using the oral contraceptive pill and Depo-Provera. It will also assess the continuation rates of Ortho Evra®, which has not previously been studied in the adolescent population. This study will provide information with regard to pregnancy rates and 3-month patterns of use of contraception among women seeking first-trimester abortion. It will also assess other factors contributing to successful contraception such as the use of emergency contraception and concomitant condom use. The results of this study will be used to inform the practice of providers who provide reproductive health care to women and add to the sparse body of literature available comparing the success of different contraceptive methods used by women.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Participants were recruited from a indigent, urban, African American population.

Contraception
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
321
November 2005
November 2005   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age 13-45 women presenting at the ambulatory surgery at Grady Memorial Hospital who want to use either oral contraceptive pills, ortho evra or depo provera?

Exclusion Criteria:

  • Leaving the Atlanta area within 6 months?
  • Desires pregnancy within the next 6 months?
  • Unable to provide contact information?
  • Contraindications to hormonal contraceptive?
Female
13 Years to 45 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00253019
518-2003
No
Carrie Cwiak, Emory University
Emory University
Not Provided
Principal Investigator: Carrie Cwiak, MD, MPH Emory University
Emory University
August 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP